1. Home
  2. SIDU vs BCDA Comparison

SIDU vs BCDA Comparison

Compare SIDU & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$3.05

Market Cap

317.4M

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$0.90

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
BCDA
Founded
2012
N/A
Country
United States
United States
Employees
N/A
21
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.4M
11.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SIDU
BCDA
Price
$3.05
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
25.5M
6.5M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
66.94
N/A
EPS
N/A
N/A
Revenue
$3,383,878.00
N/A
Revenue This Year
$171.29
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.78
52 Week High
$6.79
$2.45

Technical Indicators

Market Signals
Indicator
SIDU
BCDA
Relative Strength Index (RSI) 40.31 47.28
Support Level $2.88 $0.81
Resistance Level $3.15 $1.36
Average True Range (ATR) 0.54 0.14
MACD -0.19 0.01
Stochastic Oscillator 4.12 12.65

Price Performance

Historical Comparison
SIDU
BCDA

About SIDU Sidus Space Inc.

Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: